Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of CB-03-01 cream 1% for facial acne vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CB-03-01 cream, 1% (CB-03-01)

Snippet

Sponsor: Cassiopea SpA | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-11-20